Oligonucleotides refer to short sequences of nucleotides
(building blocks of DNA and RNA) typically used in molecular
biology and genetics research, diagnostics, therapeutics, and other
biotechnological applications.
BOSTON, May 1, 2024
/PRNewswire/ -- "According to the latest research study, the demand
for Oligonucleotides: Global Markets expected to grow from
$7.0 billion in 2023 and will reach
$11.7 billion by the end of 2028 at a
compound annual growth rate (CAGR) of 11.0% from 2023 through
2028."
This report explores the global market for making tiny bits of
genetic material called oligonucleotides, which are used in various
ways. There are four main categories: medicines made from
oligonucleotides, the bits themselves, the tools and chemicals
needed to make them, and services related to their production. We
look at how these bits are used: for research and testing, or for
treatments. The market is divided into four regions: North America, Europe, Asia-Pacific, and the Rest of the World. We
base our information on data from 2022, with predictions for 2023
to 2028. The report also talks about approved medicines, how these
bits are made, new research, market opportunities, and profiles of
key companies in this industry.
Oligonucleotides, tiny bits of genetic material, have
revolutionized science and medicine by helping us understand
genetics better and develop advanced treatments. With increased
funding for genetic research since the Human Genome Project,
scientists are using artificial gene synthesis more often. This has
led to more studies using expression analysis, which boosts the
demand for making oligonucleotides. In the UK, the Center for
Process Innovation (CPI) is working to improve how we produce these
genetic bits, collaborating with big names like AstraZeneca and
Novartis. They've already developed a medication called Inclisiran
for heart disease. In 2021, Thermo Fisher Scientific bought Henogen
S.A. from Novasep for a whopping $792
million, enhancing their capabilities in making viral
vectors for gene therapy.
For further insights and findings about the Global IoT Chips
Market, click here to gain a comprehensive understanding of its
details and discoveries.
The Oligonucleotides: Global Market is driven by factors such
as:
- Increasing use of synthesized oligos in therapeutic
applications.: More and more, scientists are using
man-made bits of genetic material called oligonucleotides in
medical treatments. These tiny bits can be designed to target
specific genes or proteins that are involved in diseases. It's like
using a precision tool to fix specific problems in the body, and
it's becoming more common as we learn more about how genes work and
how diseases develop.
- Rising government investments for synthetic biology and
genome projects.: The government is putting more money
into projects that involve making artificial genetic material and
studying entire sets of genes. This investment is increasing
because understanding genetics better can lead to new medical
treatments and other important discoveries.
- Growing focus on personalized medicine: Personalized
medicine is becoming a bigger deal. It means doctors are trying to
tailor treatments to fit each person's unique genetic makeup and
health history. By doing this, they hope to make treatments more
effective and reduce side effects.
Request a Sample Copy of the Oligonucleotides:
Global Markets.
Report
Synopsis
Report
Metrics
|
Details
|
Base year
considered
|
2022
|
Forecast Period
considered
|
2023-2028
|
Base year market
size
|
$6.3 billion
|
Market Size
Forecast
|
$11.7
billion
|
Growth Rate
|
CAGR of 11.0% for the
forecast period of 2023-2028
|
Segment
Covered
|
Type, Application, and
Region
|
Regions
covered
|
North America, Europe,
Asia-Pacific, and Rest of the World
|
Countries
covered
|
U.S., Canada, Germany,
U.K., France, Italy, Spain, China, Japan, India
|
Key Market
Drivers
|
- Increasing use of
synthesized oligos in therapeutic applications.
- Rising government
investments for synthetic biology and genome projects.
- Growing focus on
personalized medicine
|
Segmentation Analysis of Oligonucleotides: Global
Markets:
- By Product –
In the realm of products
within this domain, there are primarily four categories:
oligonucleotide drugs, which are pharmaceuticals derived from
minuscule genetic components; equipment and reagents, encompassing
the tools and chemicals essential for manipulating these
components; synthesized oligos, the artificially produced genetic
fragments themselves; and services, which entail assistance with
either the production or utilization of these
oligonucleotides.
- By Application –
In terms of how
these products are used, there are essentially two main categories:
research and diagnostics & therapeutics. Research involves
using these products for studying genetics and other scientific
investigations, while diagnostics & therapeutics refer to their
application in diagnosing diseases and developing treatments to
address them.
This report on oligonucleotides: global markets provide
comprehensive insights and analysis, addressing the following key
questions:
- What is the projected market size and growth rate of the
market?
The global market for oligonucleotide synthesis was valued at
$6.3 billion in 2022 and will reach
$11.7 billion by 2028 with a CAGR of
11% from 2023 to 2028.
- What are the key factors driving the growth of the market?
The global market for oligonucleotide synthesis is witnessing
intrinsic growth owing to the increasing use of synthesized oligos
in therapeutic applications, increasing government investments for
synthetic biology and genome projects, and a growing focus on
personalized medicine.
- What segments are covered in the market?
The global oligonucleotides market is segmented based on products,
application, and region.
- By products, which segment will dominate the market by the end
of 2028?
The Oligonucleotide Drugs segment will dominate the market in
2028.
- Which region has the highest market share in the
market?
North America holds the highest
share of the market.
Some of the Key Market Players Are:
- AGILENT TECHNOLOGIES INC.
- BIOLEGIO B.V.
- BIOLYTIC LAB PERFORMANCE INC.
- EUROFINS SCIENTIFIC
- GENSCRIPT
- INTEGRATED DNA TECHNOLOGIES INC.
- LC SCIENCES
- LGC GROUP
- MERCK KGAA
- MICROSYNTH AG
- THERMO FISHER SCIENTIFIC INC.
Browse for more Related Reports:
Polymerase Chain Reaction (PCR) Technologies and Global Markets:
is basically a detailed report that looks at a technique called
PCR, which helps scientists make copies of DNA. This technique is
super important in many fields like medicine, genetics, and solving
crimes. The report talks about how PCR is used all around the world
and how the market for PCR-related stuff, like machines and
chemicals, is doing. It covers things like how big the market is,
how fast it's growing, who the main players are, what new
technologies are coming up, and what rules and regulations are in
place.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global
Markets: is a report that looks into everything about microRNAs
(miRNAs), which are tiny molecules involved in regulating genes.
The report covers tools used for studying miRNAs, diagnostic tests
that use miRNAs to detect diseases, and potential treatments
targeting miRNAs. It explores how big the market is for these
tools, diagnostics, and treatments worldwide, how it's growing, who
the major players are, and what new developments are happening in
this field. Overall, it's a detailed study to understand what's
happening with miRNA-related research, diagnostics, and treatments
on a global level.
Directly Purchase a copy of the report with BCC
Research.
For further information or to make a purchase, please get in
touch with info@bccresearch.com.
About BCC Research
BCC Research provides objective, unbiased measurement and
assessment of market opportunities with detailed market research
reports. Our experienced industry analysts' goal is to help you
make informed business decisions, free of noise and hype.
Logo:
https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg
Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our
media page for access to our market research library.
Data and analysis extracted from this press release must be
accompanied by a statement identifying BCC Research LLC as the
source and publisher.
View original
content:https://www.prnewswire.com/news-releases/from-base-pairs-to-billions-oligonucleotides-remarkable-market-trajectory-driven-by-thriving-11-0-cagr-growth-globally-302132804.html
SOURCE BCC Research LLC